Regulation of IGFBP3 gene expression in short children born small for gestational age.

[1]  L. Gagliardi,et al.  Neonatal Anthropometric Charts: The Italian Neonatal Study Compared With Other European Studies , 2010, Journal of pediatric gastroenterology and nutrition.

[2]  A. Uitterlinden,et al.  The -G1245A IGF1 polymorphism is related with small head size and less brain sparing in small for gestational age born children. , 2009, European journal of endocrinology.

[3]  C. Deal,et al.  Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age. , 2009, The Journal of clinical endocrinology and metabolism.

[4]  E. Mayayo,et al.  Growth and growth hormone treatment in short stature children born small for gestational age. , 2009, Pediatric endocrinology reviews : PER.

[5]  Wieland Kiess,et al.  IGF signaling defects as causes of growth failure and IUGR , 2008, Trends in Endocrinology & Metabolism.

[6]  C. Deal,et al.  Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin. , 2007, Endocrinology.

[7]  Richa Saxena,et al.  A common variant of HMGA2 is associated with adult and childhood height in the general population , 2007, Nature Genetics.

[8]  P. Czernichow,et al.  Small for gestational age: short stature and beyond. , 2007, Endocrine reviews.

[9]  X. Solé,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[10]  E. Spada,et al.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) , 2006, Journal of endocrinological investigation.

[11]  L. Hulthén,et al.  Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. , 2005, The Journal of clinical endocrinology and metabolism.

[12]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[13]  M. Stampfer,et al.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[15]  P. Cohen,et al.  Genetics, chemistry, and function of the IGF/IGFBP system , 2000, Endocrine.

[16]  Alberto Costa,et al.  Effect of fenretinide on plasma IGF‐I and IGFBP‐3 in early breast cancer patients , 1998, International journal of cancer.

[17]  C. Stewart,et al.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.

[18]  M. Pollak,et al.  Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer Cells (*) , 1996, The Journal of Biological Chemistry.

[19]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[20]  D. Powell,et al.  Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. , 1990, The Journal of biological chemistry.

[21]  C. V. van Duijn,et al.  Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). , 2002, The Journal of clinical endocrinology and metabolism.

[22]  R. Baxter,et al.  Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[23]  A. Efstratiadis.  Genetics of mouse growth. , 1998, The International journal of developmental biology.

[24]  L. Phillips,et al.  Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. , 1998, Progress in nucleic acid research and molecular biology.

[25]  J. Seth.  Insulin-Like Growth Factor Binding Protein-3 , 1994 .

[26]  R. Baxter,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Impaired Blockade of Insulin-Like Growth Factor I (IGF-I)-Induced Hypoglycemia by IGF Binding Protein-3 Analog with Reduced Ternary Complex-Forming Ability , 2022 .